Molecule Details
| InChIKey | DRHXTSWSUAJOJZ-FMDGEEDCSA-N |
|---|---|
| Compound Name | N-Acetyl-glucosamine thiazoline |
| Canonical SMILES | CC1=N[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]2S1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.79 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB03747 |
|---|---|
| Drug Name | N-Acetyl-glucosamine thiazoline |
| CAS Number | 179030-22-9 |
| Groups | experimental |
| ATC Codes | nan |
| Description | N-Acetyl-glucosamine thiazoline (NAG-thiazoline) is an analog of the oxazolinium bicyclic intermediate leading from N-acetylglucosamine to 1,6-anhydro-N-acetylmuramic acid. |
Categories: Amino Sugars Carbohydrates Hexosamines Sulfur Compounds
Cross-references: BindingDB: 50327038 CHEMBL257158 ChemSpider: 4451076 PDB: NGT PubChem:5289024 PubChem:46508064 RxCUI: 2597521 ZINC: ZINC000016051892